This is unpublished

Barbara A.
Konkle
M.D.

Barbara Konkle
Physician & Research Faculty
Pinned
Academic
Professor Emeritus, Division of Hematology and Oncology, University of Washington

Education, training, board certifications

  • M.D., Vanderbilt University
  • Residency in Medicine, Rush Presbyterian-St. Luke's, Chicago
  • Fellowship in Hematology/Oncology, University of Michigan

 

 

publications

 

 

ORCID

 

Clinical and/or research career

Dr. Barbara Konkle is a leader in the field of hemostasis and thrombosis, and especially the biology, genetics, and therapy of bleeding disorders. She led the MyLifeOurFuture project which has genotypic and phenotypic data on over 11,000 hemophilia patients and potential carriers and is an NHLBI TOPMed cohort. She was lead author of a practice-changing New England Journal of Medicine paper (2020) demonstrating the efficacy of a FVIII fusion protein.  She currently co-chairs the Coagulation Factor Deficiency VCEP for the NIH-funded ClinGen initiative. Her many clinical contributions include insights into bleeding disorders in women and with aging, studies of pregnancy-related clotting and bleeding, and gene therapy in hemophilia. She is on the Board of Directors of the World Federation of Hemophilia (WFH) and chairs the WFH Gene Therapy Registry, was a founding member of the Foundation for Women and Girls with Blood Disorders, was Chair of the American Thrombosis and Hemostasis Network, was a member of the NHLBI Advisory Council and American Board of Internal Medicine (ABIM) Subspecialty Board on Hematology, and has significantly contributed to other national and international hematology organizations. Dr. Konkle is the recipient of the International Society of Thrombosis and Hemostasis Esteemed Career Award (2021). Locally, she was a Professor in the Division of Hematology and Oncology and served in several leadership positions at BloodWorks NW Washington and the Washington Center for Bleeding Disorders.